More about
Advanced Blood Cancers
News
October 07, 2024
2 min read
Save
Serious cardiovascular events rare after CAR T-cell therapy
A meta-analysis of patients who underwent chimeric antigen receptor T-cell therapy for advanced blood cancers showed low prevalence of cardiovascular adverse events.